C33H34FN7O8S — CID 172511170
(2R)-2-[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]piperidin-4-yl]-N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]propanamide (PubChem CID 172511170) has the molecular formula C33H34FN7O8S and a molecular weight of 707.74 g/mol. Its IUPAC name is (2R)-2-[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]piperidin-4-yl]-N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]propanamide.
| Compound Name | (2R)-2-[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]piperidin-4-yl]-N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]propanamide |
|---|---|
| PubChem CID | 172511170 |
| Molecular Formula | C33H34FN7O8S |
| Molecular Weight | 707.74 g/mol |
| Exact Mass | 707.22 |
| IUPAC Name | (2R)-2-[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]piperidin-4-yl]-N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]propanamide |
| SMILES | C[C@@H](C(=O)Nc1ccc2c(F)c(N3CC(=O)NS3(=O)=O)c(O)cc2c1)C1CCN(c2ccc3c(c2)n(C)c(=O)n3C2CCC(=O)NC2=O)CC1 |
| InChI | InChI=1S/C33H34FN7O8S/c1-17(31(45)35-20-3-5-22-19(13-20)14-26(42)30(29(22)34)40-16-28(44)37-50(40,48)49)18-9-11-39(12-10-18)21-4-6-23-25(15-21)38(2)33(47)41(23)24-7-8-27(43)36-32(24)46/h3-6,13-15,17-18,24,42H,7-12,16H2,1-2H3,(H,35,45)(H,37,44)(H,36,43,46)/t17-,24?/m1/s1 |
| InChIKey | OQFRGOFRVKAUJT-BPNWFJGMSA-N |
| XLogP | 1.99 |
| TPSA | 192.15 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 50 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 707.74 |
| LogP ≤ 5 | 1.99 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 11 |
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|